國家衛生研究院 NHRI:Item 3990099045/10642
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 916116      線上人數 : 1391
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/10642


    題名: Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-gamma autoantibodies in patients with disseminated nontuberculous mycobacterial infection
    其他題名: Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection
    作者: Wu, UI;Chuang, YC;Sheng, WH;Sun, HY;Jhong, YT;Wang, JY;Chang, SC;Wang, JT;Chen, YC
    貢獻者: Division of Infectious Diseases
    摘要: OBJECTIVE: Anti-interferon-gamma (IFN-gamma) autoantibodies (anti-IFN-gamma Abs) have been increasingly recognized as an important cause of disseminated nontuberculous mycobacterial (DNTM) infection, and identification of this immunodeficiency impacts clinical management. However, the protean disease manifestations and inaccessibility to diagnostic tests in clinical settings hamper its early diagnosis. Here, we sought to determine whether QuantiFERON-TB Gold In-tube (QFT-GIT), a commercialized IFN-gamma release assay, could be used to screen for neutralizing anti-IFN-gamma Abs among previously healthy adults with DNTM infection. METHODS: HIV-uninfected patients with DNTM infection were prospectively enrolled for the QFT-GIT assays. We measured their plasma concentration of anti-IFN-gamma Abs and their neutralizing capacity through enzyme-linked immunosorbent assay and flow cytometry. We then analyzed the correlation between QFT-GIT results and the presence of neutralizing anti-IFN-gamma Abs among patients with and without previously recognized immunosuppression, respectively. RESULTS: Irrespective of the autoantibody concentration or disease activity, all patients with neutralizing anti-IFN-gamma Abs (100%, 30/30) had indeterminate QFT-GIT results due to extremely low or undetectable IFN-gamma levels in the mitogen tubes. None of the four DNTM patients who were previously healthy and tested negative of anti-IFN-gamma Abs had an indeterminate QFT-GIT result, and their IFN-gamma levels in the mitogen tube were significantly higher than those of the patients with anti-IFN-gamma Abs (8.28 IU/mL vs. 0.05 IU/mL, P = 0.001). CONCLUSION: An indeterminate QFT-GIT result due to undetectable or extremely low IFN-gamma level in the mitogen tube suggests the presence of neutralizing anti-IFN-gamma Abs in a previously healthy patient with DNTM infection.
    日期: 2018-02
    關聯: Clinical Microbiology and Infection. 2018 Feb;24(2):159-165.
    Link to: http://dx.doi.org/10.1016/j.cmi.2017.06.029
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1198-743x&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000424846600013
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85027467124
    顯示於類別:[陳宜君] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB28694201.pdf613KbAdobe PDF380檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋